Unproven Clinical Value of Interim FDG-PET in Aggressive Non-Hodgkin Lymphoma

被引：1
作者：
Adams, Hugo J. A. [1 ]
Kwee, Thomas C. [2 ]
机构：
[1] Amsterdam UMC, Amsterdam, Netherlands
[2] Univ Med Ctr Groningen, Groningen, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 32期
关键词：
B-CELL LYMPHOMA; NCCN-IPI;
D O I：
10.1200/JCO.18.00323
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3271 / +
页数：3
相关论文
共 5 条
[1]   Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: Systematic review and meta-analysis [J].
Adams, Hugo J. A. ;
Kwee, Thomas C. .
EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (11) :1963-1970
[2]   Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial [J].
Duehrsen, Ulrich ;
Mueller, Stefan ;
Hertenstein, Bernd ;
Thomssen, Henrike ;
Kotzerke, Joerg ;
Mesters, Rolf ;
Berdel, Wolfgang E. ;
Franzius, Christiane ;
Kroschinsky, Frank ;
Weckesser, Matthias ;
Kofahl-Krause, Dorothea ;
Bengel, Frank M. ;
Duerig, Jan ;
Matschke, Johannes ;
Schmitz, Christine ;
Poeppel, Thorsten ;
Ose, Claudia ;
Brinkmann, Marcus ;
La Rosee, Paul ;
Freesmeyer, Martin ;
Hertel, Andreas ;
Hoeffkes, Heinz-Gert ;
Behringer, Dirk ;
Prange-Krex, Gabriele ;
Wilop, Stefan ;
Krohn, Thomas ;
Holzinger, Jens ;
Griesshammer, Martin ;
Giagounidis, Aristoteles ;
Raghavachar, Aruna ;
Maschmeyer, Georg ;
Brink, Ingo ;
Bernhard, Helga ;
Haberkorn, Uwe ;
Gaska, Tobias ;
Kurch, Lars ;
van Assema, Danielle M. E. ;
Klapper, Wolfram ;
Hoelzer, Dieter ;
Geworski, Lilli ;
Joeckel, Karl-Heinz ;
Scherag, Andre ;
Bockisch, Andreas ;
Rekowski, Jan ;
Huettmann, Andreas .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (20) :2024-+
[3]   Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI [J].
Melchardt, Thomas ;
Troppan, Katharina ;
Weiss, Lukas ;
Hufnagl, Clemens ;
Neureiter, Daniel ;
Traenkenschuh, Wolfgang ;
Schlick, Konstantin ;
Huemer, Florian ;
Deutsch, Alexander ;
Neumeister, Peter ;
Greil, Richard ;
Pichler, Martin ;
Egle, Alexander .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (12) :1501-1508
[4]   Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β2-microglobulin yields a more accurate GELTAMO-IPI [J].
Montalban, Carlos ;
Diaz-Lopez, Antonio ;
Dlouhy, Ivan ;
Rovira, Jordina ;
Lopez-Guillmermo, Armando ;
Alonso, Sara ;
Martin, Alejandro ;
Sancho, Juan M. ;
Garcia, Olga ;
Sanchez, Jose M. ;
Rodriguez, Mario ;
Novelli, Silvana ;
Salar, Antonio ;
Gutierrez, Antonio ;
Rodriguez-Salazar, Maria J. ;
Bastos, Mariana ;
Dominguez, Juan F. ;
Fernandez, Ruben ;
de Villambrosia, Sonia Gonzalez ;
Queizan, Jose E. A. ;
Cordoba, Raul ;
de Ona, Raquel ;
Lopez-Hernandez, Andres ;
Freue, Julian M. ;
Garrote, Heidys ;
Lopez, Lourdes ;
Martin-Moreno, Ana M. ;
Rodriguez, Jose ;
Abraira, Victor ;
Garcia, Juan F. .
BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (06) :918-928
[5]   NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients [J].
Prochazka, Katharina T. ;
Melchardt, Thomas ;
Posch, Florian ;
Schlick, Konstantin ;
Deutsch, Alexander ;
Beham-Schmid, Christine ;
Weiss, Lukas ;
Gary, Thomas ;
Neureiter, Daniel ;
Klieser, Eckhard ;
Greil, Richard ;
Neumeister, Peter ;
Egle, Alexander ;
Pichler, Martin .
BRITISH JOURNAL OF CANCER, 2016, 115 (10) :1264-1272
1